Author

Mariam Aguas 1

1 Ho

CAN A PATIENT RATE THE ACTIVITY OF THEIR CROHN´S DISEASE THROUGH A MOBILE APP? THE MEDICROHN STUDY. 

Ana Echarri Piudo, Isabel Vera Mendoza, Jordi Guardiola Capon, Virginia Ollero, Beatriz Castro, Francisco Gallego, Mariam Aguas, Maria Chaparro Sanchez, D Ceballos, Claudia Arajol, Pilar Robledo Andrés, Sabino Riestra, Ignacio Marín-Jiménez, Pilar Nos Mateu, S García-López

Real life experience of first line anti-TNF in Crohn´s disease patients in Spain: do we have data to choose between infliximab and adalimumab?

Ignacio Marín-Jiménez, Guillermo Bastida, Ana Fores, Federico Argüelles-Arias, Ignacio Tagarro, Alonso Fernandez, Carmen Montoto Otero, Mariam Aguas, Rocio Ferreiro Iglesias, Olga Merino, Javier Santos Fernandez, Xavier Cortés, Francisco Mesonero Gismero, Manuel Barreiro de Acosta

SAFETY OF INFLAMMATORY BOWEL DISEASE DRUGS DURING PREGNANCY AND BREASTFEEDING: MOTHERS AND BABIES' OUTCOMES (DUMBO REGISTRY)

Maria Chaparro, María G. Donday, Rubio Saioa, Cristina Calviño Suarez, Montserrat Figueira, Ana Gutierrez Casbas, Patricia Ramírez-de la Piscina, Alexandra Ruiz Cerulla, Isabel Perez Martinez, Cristina Suárez Ferrer, Pilar López Serrano, Iago Rodríguez-Lago, María José Casanova, Ivan Guerra, Daniel Hervías Cruz, Juan Maria V

Item 1 - 3 / 9
1